Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure: an update on pathophysiology

H Drexler1

  • 1Medizinische Klinik III, University of Freiburg, Germany.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control study.

Journal of occupational medicine and toxicology (London, England)·2020
Same author

[Changes to the Law on Occupational Diseases and Consequences for Medical Assessment].

Pneumologie (Stuttgart, Germany)·2020
Same author

Impact of physiologically relevant temperatures on dermal absorption of active substances - an ex-vivo study in human skin.

Toxicology in vitro : an international journal published in association with BIBRA·2020
Same author

[Rare occupational diseases].

Der Internist·2020
Same author

Evaluation of urinary selenium as a biomarker of human occupational exposure to elemental and inorganic selenium.

International archives of occupational and environmental health·2019
Same author

Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181.

The British journal of dermatology·2017
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Myocardial hypertrophy, a risk factor for heart disease, involves altered gene expression and calcium handling. Angiotensin II contributes to these changes, but ACE inhibition can improve outcomes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Myocardial hypertrophy is a significant risk factor for cardiovascular morbidity and mortality.
  • Hypertrophy alters cardiac gene expression, leading to a fetal-like myocyte phenotype and impaired calcium homeostasis.
  • Key molecular changes include depressed sarcoplasmic reticulum ATPase and upregulated sodium-calcium exchanger activity.

Purpose of the Study:

  • To investigate the role of Angiotensin II in cardiac hypertrophy and phenotype shift.
  • To examine the impact of Angiotensin II on cardiac gene expression, specifically angiotensin converting enzyme and angiotensinogen.
  • To evaluate the effects of chronic ACE inhibition on left ventricular hypertrophy and survival.

Main Methods:

  • Analysis of cardiac gene expression in response to overload.

Related Experiment Videos

  • Assessment of Angiotensin II's role in cardiac hypertrophy.
  • Evaluation of chronic ACE inhibition effects on cardiac structure and survival.

    • Main Results:

    • Cardiac Angiotensin II formation contributes to hypertrophy and phenotype shift.
    • Angiotensin converting enzyme and angiotensinogen gene expression increase early after cardiac overload.
    • Chronic ACE inhibition reduces left ventricular hypertrophy and improves survival.

    Conclusions:

    • Angiotensin II plays a crucial role in mediating cardiac hypertrophy and associated molecular changes.
    • ACE inhibition is a viable therapeutic strategy for managing cardiac hypertrophy and improving outcomes in heart failure.
    • Peripheral adaptations, including endothelial dysfunction and skeletal muscle alterations, contribute to reduced exercise performance in heart failure.